These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6454278)

  • 21. Von Willebrand Factor (VIIIVWF) in lyophilized Factor VIII concentrates.
    McCue MJ; Brossoit AD; Marmer DJ; Head DR
    Am J Hematol; 1980; 9(1):39-42. PubMed ID: 6776806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.
    Zimmerman TS; Voss R; Edgington TS
    J Clin Invest; 1979 Nov; 64(5):1298-302. PubMed ID: 315413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some immunofluorescent observations on factor VIII/von Willebrand factor in dogs.
    Potter EV; Shaughnessy MA; Green D
    Thromb Haemost; 1980 Oct; 44(2):56-61. PubMed ID: 6779399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sugar-chain of factor VIII/von Willebrand factor in von Willebrand's disease. Analysis by immuno-affinoelectrophoresis using lectin].
    Ueda M; Yasui M; Nishino M; Mikami S; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1117-23. PubMed ID: 6421045
    [No Abstract]   [Full Text] [Related]  

  • 25. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies on the dynamics of plasma factor VIII/von Willebrand factor activity in cerebrovascular diseases].
    Shinmyozu K; Maruyama Y; Ohkatsu Y; Maruyama I; Igata A
    Rinsho Shinkeigaku; 1983 Feb; 23(2):172-9. PubMed ID: 6407797
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.
    Hamilton KK; Fretto LJ; Grierson DS; McKee PA
    J Clin Invest; 1985 Jul; 76(1):261-70. PubMed ID: 3160727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular structural studies of human factor VIII.
    McKee PA; Andersen JC; Switzer ME
    Ann N Y Acad Sci; 1975 Jan; 240():8-33. PubMed ID: 122889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women.
    Tanaka KA; Bharadwaj S; Hasan S; Judd M; Abuelkasem E; Henderson RA; Chow JH; Williams B; Mazzeffi MA; Crimmins SD; Malinow AM
    Br J Anaesth; 2019 Jun; 122(6):751-759. PubMed ID: 30916034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The in vitro association of antihemophilic factor and von Willebrand factor.
    Zucker MB; Soberano ME; Johnson AJ; Fulton AJ; Kowalski S; Adler M
    Thromb Haemost; 1983 Feb; 49(1):37-41. PubMed ID: 6405497
    [No Abstract]   [Full Text] [Related]  

  • 31. Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease.
    Fass DN; Brockway WJ; Owen CA; Bowie EJ
    Thromb Res; 1976 Mar; 8(3):319-27. PubMed ID: 1083569
    [No Abstract]   [Full Text] [Related]  

  • 32. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates.
    Budde U; Drewke E
    Beitr Infusionsther Transfusionsmed; 1994; 32():408-14. PubMed ID: 9422121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure.
    Warrell RP; Hultin MB; Coller BS
    Am J Med; 1979 Feb; 66(2):226-8. PubMed ID: 311586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary results on the carbohydrate moiety of factor VIII/von Willebrand factor (FVIII/vWf).
    Samor B; Mazurier C; Goudemand M; Debeire P; Fournet B; Montreuil J
    Thromb Res; 1982 Jan 1-15; 25(1-2):81-9. PubMed ID: 6801813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactivity of small molecular forms of human factor VIII/von Willebrand factor with botrocetin and anti-factor VIII-coated latex particles.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1985 Aug; 54(2):463-5. PubMed ID: 3936216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of a coagulation accelerating factor (CAF) in glomerulonephritis.
    Salem HH; Howard MA; Koutts J; Firkin BG
    Br J Haematol; 1985 Mar; 59(3):485-96. PubMed ID: 3918561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of high ionic strength buffers on factor VIII/von Willebrand factor from different species.
    Lavergne JM; Meyer D; Jenkins CS; Obert B; Larrieu MJ
    Thromb Res; 1978 Sep; 13(3):409-18. PubMed ID: 311086
    [No Abstract]   [Full Text] [Related]  

  • 38. Antihaemophilic factor A activity, F VIII-related antigen and von Wilebrand factor in hepatic cirrhosis.
    Baele G; Matthijs E; Barbier F
    Acta Haematol; 1977; 57(5):290-7. PubMed ID: 403732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoradiometric assays for factor VIII antigens: coagulant protein (antihemophilic factor) and factor VIII-related protein (von Willebrand factor).
    Hoyer LW; Trabold NC
    Methods Enzymol; 1982; 84():51-60. PubMed ID: 6808318
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of thrombin on the complex between factor VIII and von Willebrand factor.
    Hamer RJ; Koedam JA; Beeser-Visser NH; Sixma JJ
    Eur J Biochem; 1987 Sep; 167(2):253-9. PubMed ID: 3113951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.